Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Markers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00862108
What this trial is testing

Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)

Who this might be right for
Attention Deficit Hyperactivity Disorder
Seoul National University Hospital 50
Not applicableStudy completedNCT05551403
What this trial is testing

Cortical Excitability and Treatment Response in People with Epilepsy

Who this might be right for
Epilepsy
Stichting Epilepsie Instellingen Nederland 28
Not applicableStudy completedNCT02557464
What this trial is testing

Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading.

Who this might be right for
Alzheimer's Disease
Centre Hospitalier Universitaire de Nice 14
Not applicableStudy completedNCT05035628
What this trial is testing

Cardiopulmonary Rehabilitation in Long COVID-19 Patients With Persistent Breathlessness and Fatigue

Who this might be right for
COVID-19 Respiratory Infection
Louis Bherer 40
Not applicableEnded earlyNCT00646308
What this trial is testing

Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas

Who this might be right for
Growth Hormone DeficiencyPituitary Tumor
Columbia University 60
Not applicableStudy completedNCT00872131
What this trial is testing

Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder

Who this might be right for
Anxiety Disorders
University of Michigan 200
Not applicableStudy completedNCT05537688
What this trial is testing

Identification of Graphic Markers of Neurocognitive Disorders (MG)

Who this might be right for
Alzheimer DiseasePrimary Progressive AphasiaNeurocognitive Disorders
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal 53
Large-scale testing (Phase 3)Ended earlyNCT00843154
What this trial is testing

Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart Failure

Who this might be right for
Heart Failure
Takeda 571
Not applicableStudy completedNCT05812742
What this trial is testing

Chasing Biomarkers in Post-concussion Syndrome

Who this might be right for
Post Concussive Symptoms
University of Aarhus 86
Not applicableLooking for participantsNCT06462274
What this trial is testing

Biomarkers and Imaging Markers for ICH

Who this might be right for
Intracerebral Hemorrhage
Southwest Hospital, China 200
Not applicableStudy completedNCT00587717
What this trial is testing

The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue

Who this might be right for
Carotid Artery Disease
Mayo Clinic 35
Not applicableStudy completedNCT02089555
What this trial is testing

African American Alzheimer's Progression Markers - CSF and Neuro-Imaging

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's Disease
Emory University 135
Not applicableLooking for participantsNCT07464938
What this trial is testing

New Tools and Predictive Markers in the Prognosis of Hypoxic-ischemic Encephalopathy Following Cardiac Arrest

Who this might be right for
Cardiac Arrest (CA)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 50
Not applicableStudy completedNCT02935985
What this trial is testing

Emergency Management of Spontaneous Intracerebral Haemorrhage - Biomarkers

Who this might be right for
Cerebral Hemorrhage
Iuliu Hatieganu University of Medicine and Pharmacy 39
Post-approval studies (Phase 4)Study completedNCT00256126
What this trial is testing

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Who this might be right for
Growth Hormone DeficiencyTurner Syndrome
Merck KGaA, Darmstadt, Germany 318
Not applicableUnknownNCT05553990
What this trial is testing

Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of AIS With Active Cancer

Who this might be right for
Ischemic Stroke, AcuteTumor Progression
Nanfang Hospital, Southern Medical University 200
Not applicableUnknownNCT05551923
What this trial is testing

Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of Cerebral Hemorrhage

Who this might be right for
Hemorrhagic StrokeAcuteOutcomes+2 more
Nanfang Hospital, Southern Medical University 300
Not applicableStudy completedNCT01655160
What this trial is testing

Effects and Mechanisms of Treatment Intensity of Mirror Therapy in Patients With Subacute Stroke

Who this might be right for
Cerebrovascular Accident
Chang Gung Memorial Hospital 2
Not applicableStudy completedNCT03845686
What this trial is testing

Brain Markers Predicting Reading Recovery After Stroke

Who this might be right for
Left-Hemisphere Stroke
Kessler Foundation 26
Not applicableUnknownNCT02930512
What this trial is testing

Study of Factors Associated With the Volumetric and Areal Bone Mineral Density and Bone Strength in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Hospital, Clermont-Ferrand 200
Next Page